author-photo

Veronika Schuster

Ludwig Maximilian University of Munich

2

Papers

1

Citations

Citation Trend

Filter By

Papers (2) Sort By

JournalConferenceOthers

Consensus molecular subtypes and RAS status as biomarker of treatment intensity with fluoropyrimidine, bevacizumab, and irinotecan in metastatic colorectal cancer (XELAVIRI, AIO KRK 0110).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial).

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (1)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号